Evidence map›Paper›PMID 22028813›Full record

ArticlePloS one2011

Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.

Vanessa F Bonazzi, Derek J Nancarrow, Mitchell S Stark, Ralf J Moser, Glen M Boyle, Lauren G Aoude, Christopher Schmidt, Nicholas K Hayward

Abstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. A prognostic model based on the COL1A1-network in gastric cancer.American journal of translational research · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial-mesenchymal transition in liver cancer cells.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. miR-193b and miR-30c-1Oncotarget · 2018
    Article
  20. Melanoma in patients with GATA2 deficiency.Pigment cell & melanoma research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vanessa F BonazziOncogenomics Laboratory, Queensland Institute of Medical Research, Herston, Brisbane, Queensland, Australia. vanessa.bonazzi@qimr.edu.au
Derek J Nancarrow
Mitchell S Stark
Ralf J Moser
Glen M Boyle
Lauren G Aoude
Christopher Schmidt
Nicholas K Hayward

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epigenetic regulation of tumor suppressor genes (TSGs) has been shown to play a central role in melanomagenesis. By integrating gene expression and methylation array analysis we identified novel candidate genes frequently methylated in melanoma. We validated the methylation status of the most promising genes using highly sensitive Sequenom Epityper assays in a large panel of melanoma cell lines and resected melanomas, and compared the findings with those from cultured melanocytes. We found transcript levels of UCHL1, COL1A2, THBS1 and TNFRSF10D were inversely correlated with promoter methylation. For THBS1 and UCHL1 the effect of this methylation on expression was confirmed at the protein level. Identification of these candidate TSGs and future research designed to understand how their silencing is related to melanoma development will increase our understanding of the etiology of this cancer and may provide tools for its early diagnosis.

Indexed as

Gene SilencingGenes, Tumor SuppressorAnimalsCell Line, TumorCollagen Type ICpG IslandsDNA MethylationHumansInfant, NewbornMelanomaOligonucleotide Array Sequence AnalysisPromoter Regions, GeneticRNA, MessengerSkin NeoplasmsThrombospondin 1Tumor Necrosis Factor Decoy ReceptorsCollagen Type IRNA, MessengerThrombospondin 1TNFRSF10D protein, humanTumor Necrosis Factor Decoy ReceptorsUbiquitin ThiolesteraseUCHL1 protein, human

Identifiers

PMID22028813
PMCPMC3197591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.